203 related articles for article (PubMed ID: 11410074)
21. A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine.
Saper JR; Mathew NT; Loder EW; DeGryse R; VanDenburgh AM;
Pain Med; 2007 Sep; 8(6):478-85. PubMed ID: 17716321
[TBL] [Abstract][Full Text] [Related]
22. Monograph. Petasites hybridus.
Altern Med Rev; 2001 Apr; 6(2):207-9. PubMed ID: 11302783
[TBL] [Abstract][Full Text] [Related]
23. Prevention of migraine with olmesartan in patients with hypertension/prehypertension.
Charles JA; Jotkowitz S; Byrd LH
Headache; 2006 Mar; 46(3):503-7. PubMed ID: 16618270
[TBL] [Abstract][Full Text] [Related]
24. Open-label trial of cinnarizine in migraine prophylaxis.
Togha M; Ashrafian H; Tajik P
Headache; 2006 Mar; 46(3):498-502. PubMed ID: 16618269
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
[TBL] [Abstract][Full Text] [Related]
26. A randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis.
Magis D; Ambrosini A; Sándor P; Jacquy J; Laloux P; Schoenen J
Headache; 2007 Jan; 47(1):52-7. PubMed ID: 17355494
[TBL] [Abstract][Full Text] [Related]
27. European multicenter trial of nimodipine in the prophylaxis of classic migraine (migraine with aura). Migraine-Nimodipine European Study Group (MINES).
Headache; 1989 Nov; 29(10):639-42. PubMed ID: 2693406
[TBL] [Abstract][Full Text] [Related]
28. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
[TBL] [Abstract][Full Text] [Related]
29. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
[TBL] [Abstract][Full Text] [Related]
30. Treating intermittent allergic rhinitis: a prospective, randomized, placebo and antihistamine-controlled study of Butterbur extract Ze 339.
Schapowal A;
Phytother Res; 2005 Jun; 19(6):530-7. PubMed ID: 16114089
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness and tolerability of acupuncture compared with metoprolol in migraine prophylaxis.
Streng A; Linde K; Hoppe A; Pfaffenrath V; Hammes M; Wagenpfeil S; Weidenhammer W; Melchart D
Headache; 2006; 46(10):1492-502. PubMed ID: 17115982
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of phenazone in the treatment of acute migraine attacks: a double-blind, placebo-controlled, randomized study.
Göbel H; Heinze A; Niederberger U; Witt T; Zumbroich V
Cephalalgia; 2004 Oct; 24(10):888-93. PubMed ID: 15377321
[TBL] [Abstract][Full Text] [Related]
33. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
[TBL] [Abstract][Full Text] [Related]
34. A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches.
Relja M; Poole AC; Schoenen J; Pascual J; Lei X; Thompson C;
Cephalalgia; 2007 Jun; 27(6):492-503. PubMed ID: 17428299
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
Diener HC
Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
[TBL] [Abstract][Full Text] [Related]
36. Effect of low-intensity acenocoumarol on frequency and severity of migraine attacks.
Wammes-van der Heijden EA; Smidt MH; Tijssen CC; van't Hoff AR; Lenderink AW; Egberts AC
Headache; 2005 Feb; 45(2):137-43. PubMed ID: 15705119
[TBL] [Abstract][Full Text] [Related]
37. A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine.
Aurora SK; Rozen TD; Kori SH; Shrewsbury SB
Headache; 2009 Jun; 49(6):826-37. PubMed ID: 19545249
[TBL] [Abstract][Full Text] [Related]
38. Butterbur extract: prophylactic treatment for childhood migraines.
Utterback G; Zacharias R; Timraz S; Mershman D
Complement Ther Clin Pract; 2014 Feb; 20(1):61-4. PubMed ID: 24439647
[TBL] [Abstract][Full Text] [Related]
39. Toxicogenomics applied to cultures of human hepatocytes enabled an identification of novel petasites hybridus extracts for the treatment of migraine with improved hepatobiliary safety.
Anderson N; Meier T; Borlak J
Toxicol Sci; 2009 Dec; 112(2):507-20. PubMed ID: 19770483
[TBL] [Abstract][Full Text] [Related]
40. A double blind controlled study of propranolol and cyproheptadine in migraine prophylaxis.
Rao BS; Das DG; Taraknath VR; Sarma Y
Neurol India; 2000 Sep; 48(3):223-6. PubMed ID: 11025624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
